Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Acute Lymphoblastic LeukemiaBurkitt's Lymphoma
Interventions
DRUG

RITUXIMAB

375 mg/m2/d day 1

Trial Locations (15)

Unknown

Hospital General de Alicante, Alicante

"Hospital Santa Creu i Sant Pau", Barcelona

Hospital Clínico y Provincial de Barcelona, Barcelona

Hospital Juan Canalejo, A Coruña

Hospital Clínico San Carlos de Madrid, Madrid

Hospital Doce de Octubre, Madrid

Hospital Universitario Morales Meseguer, Murcia, Murcia

Hospital Carlos Haya, Málaga

Hospital Son Dureta, Palma de Mallorca

Hospital Universitario Virgen del Rocío, Seville

Hospital La Fe, Valencia

Complejo Hospitalario de Cáceres, Cáceres

Hospital general de Jerez de la Frontera, Jerez de la Frontera

Hospital Clínico Universitario de Salamanca, Salamanca

Hospital Txagorritxu, Vitoria-Gasteiz

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00388193 - Rituximab Combined With Chemotherapy in Burkitt's Lymphoma | Biotech Hunter | Biotech Hunter